期刊文献+

偏瘫患者脑脊液胱抑素C含量检测及分析 被引量:3

Detection and analysis of the patients with hemiplegia cerbrospinal fluid cystatin C content
下载PDF
导出
摘要 目的:通过检测脑卒中不同程度偏瘫患者脑脊液胱抑素C含量改变,为临床提供诊断和治疗依据及预防干预措施。方法:以37例脑卒中偏瘫患者为研究对象,分为轻瘫、不完全性瘫和全瘫3组,测定其脑脊液中胱抑素C的含量,用微粒子增强比浊法与20例正常组对照进行分析。结果:脑卒中偏瘫患者脑脊液胱抑素C含量均低于对照组(P<0.01),且与病情呈反向关系,差异有统计学意义。结论:脑卒中偏瘫患者脑脊液胱抑素C的改变与脑部病况相关,含量值大小与病情轻重相关;治疗及预防干预对本病的康复有积极的作用。 Objective: By detecting cerebral breeders cystatin C levels in cerebrospinal fluid of patients with hemiplegia due to various changes,basis for clinical diagnosis and treatment and prevention interventions.Methods:In 37 patients with hemiplegia due to cerebral breeders for the study,and divided into paresis,group incomplete paraplegia and complete paralysis group,determination of cystatin C concentration in the cerebrospinal fluid,micro-particle enhanced turbidimetric method used with the normal set of comparative statistical analysis of 20 cases.Results:In cerebrospinal fluid in patients with hemiplegia after cerebral breeders cystatin C levels were lower than the control group(P0.01),and inversely as the severity,significance of statistically significant differences.Conclusions:Cystatin C in cerebrospinal fluid in patients with cerebral hemiplegia due to sudden changes and conditions related to the brain,content size value and the relationship between illness severity scale,treatment and prevention intervention has a positive effect on the rehabilitation of the disease.
出处 《护理实践与研究》 2012年第13期97-98,共2页 Nursing Practice and Research
基金 广东省湛江市科技计划项目2008年立项课题(2008C03006)
关键词 脑卒中 偏瘫 脑脊液 胱抑素C Stroke Hemiplegia Cerebrospinal fluid Cystatin C
  • 相关文献

参考文献5

二级参考文献33

共引文献152

同被引文献36

  • 1向礼贤.血清胱抑素C检测与疾病[J].四川医学,2004,25(11):1258-1259. 被引量:31
  • 2YangXIANG Dong-SongNIE JianWANG Xiao-JunTAN YunDENG Shu-WeiLUO Guang-XiuLU.Cloning,Characterization and Primary Function Study of a Novel Gene,Cymg1,Related to Family 2 Cystatins[J].Acta Biochimica et Biophysica Sinica,2005,37(1):11-18. 被引量:8
  • 3Lindholt JS, Erlandsen [J, Henneberg EW. Cystat in C deficiency is associated with the progression o{ small ab- dominalaortic aneurysms [J]. Br J Surg, 2001,88 ( 11 ) : 1472-1475.
  • 4Font R,Prats M,Gutifirrez C,et al. Is there a relationship between cystatin C and inflammatory status, oxidative stress and other cardiovascular risk factors in non-diabetic patients with chronic kidney diseaseFJ]. Nfrologia, 2009, 29(3) : 228-35.
  • 5Ix ]H, Shlipak MG, Chertow GM, et al. Association of cystatin C with mortality,cardiovascular events, and inci- dent heart failure among persons with coronary heart dis- ease: data from the Heart and Soul Study[J]. Circulation,2007,115(2):173-179.
  • 6Sarnak MJ, Katz R, Stehman-Breen CO, et al. Cystatin C concentration as a risk factor for heart failure in older a dults[J]. Ann Intern Med,2005,142(7) :497-505.
  • 7Lassus J, Harjola VP, Sund R, et al. Prognostic value of cystatin C in acute heart failure in re lat ion to other markers of renal function and NT-proBNP[-J]. Eur Heart J, 2007,10(24) : 811-817.
  • 8Watanabe S, Okura T, Liu J, et al. Serum cystatin C level is a marker of endorgan damage in patients with essential hypertension[J]. Hypertens Res, 2003,26 (61) : 895-899.
  • 9Nakamura Y,Takeda M, Suzuki H, et al. Abnormal dis tribution of cathepsins in the brain of patients with Alzheimer's disease[J]. Neurosci Lett, 1991 , 130 (64) : 195-198.
  • 10Trabandt A,Gay RE, Fassbender HG, et al. Cathepsin B in synovial cells at the site of joint destruction in rheuma- toid arthritis[J]. Arthritis Rheum, 1991,34 (11) : 1444- 1451.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部